ArticleGene therapy2011
Down-modulation of cancer targets using locked nucleic acid (LNA)-based antisense oligonucleotides without transfection.
Y Zhang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
41 papers cite it
this papercites it